Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00653354 · ClinicalTrials.gov registry record · Phase 3
Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 360
- Enrollment target
NCT00653354 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 360 participants.
The verdict
NCT00653354, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 360 participants
- Enrollment target
Study Summary
To assess the analgesic efficacy and general safety of 2 dosing regimens of valdecoxib compared to placebo on the first post-operative day in patients with moderate or severe pain following bunionectomy surgery.
Interventions
- DRUG placebo
- DRUG valdecoxib
- DRUG valdecoxib/placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2002-12 |
| Est. Completion | 2003-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00653354
The ClinicalTrials.gov registry entry for NCT00653354 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00653354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00653354 about?
NCT00653354 is a clinical study titled "Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery". To assess the analgesic efficacy and general safety of 2 dosing regimens of valdecoxib compared to placebo on the first post-operative day in patients with moderate or severe pain following bunionectomy surgery.
What is the current status of trial NCT00653354?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2002-12. Estimated completion is 2003-03.
What interventions are being tested in trial NCT00653354?
The interventions under investigation include: placebo (DRUG), valdecoxib (DRUG), valdecoxib/placebo (DRUG).
Who is sponsoring clinical trial NCT00653354?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.